Clinical studies in South Africa appear to have found no evidence that this vaccine has full efficacy against the variant, known as 501Y.V2 or B1.351. The plan was to inoculate the nation’s health workers first, before eventually vaccinating 40 million South Africans. Workers load South Africa's first COVID-19 vaccine as they arrive at OR Tambo airport in Johannesburg, Feb. 1, 2021. “And we're also going to see a next generation of vaccines, vaccines that are intended to actually be much broader. Mkhize said South Africa is leaving no stone unturned and in talks with other manufacturers, including those behind the Russian-developed Sputnik vaccine.

Source: Ethiopian News February 08, 2021 17:15 UTC